跳转至内容
Merck
CN

173452

4-苯基偶氮苯甲酰氯

97%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
C6H5N=NC6H4COCl
化学文摘社编号:
分子量:
244.68
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
203-188-4
MDL number:
Assay:
97%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


assay

97%

mp

94-97 °C (lit.)

SMILES string

ClC(=O)c1ccc(cc1)\N=N\c2ccccc2

InChI

1S/C13H9ClN2O/c14-13(17)10-6-8-12(9-7-10)16-15-11-4-2-1-3-5-11/h1-9H/b16-15+

InChI key

RYMHZBAYPLCCAC-FOCLMDBBSA-N

Application

4-(Phenylazo)benzoyl chloride was used in the synthesis of polyacetylene derivatives.


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

存储类别

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Antje Modrow et al.
Dalton transactions (Cambridge, England : 2003), 41(28), 8690-8696 (2012-06-14)
For the first time an azo functionality was covalently introduced into a MOF by post-synthetic modification. The reaction of Cr-MIL-101-NH(2) with p-phenylazobenzoylchloride (1) and 4-(phenylazo)phenylisocyanate (2) as the reactants led to the compounds Cr-MIL-101_amide and Cr-MIL-101_urea, with the azo groups
Yeong-Soon Gal et al.
Journal of nanoscience and nanotechnology, 11(8), 7386-7389 (2011-11-23)
A new polyacetylene derivative was prepared by the activated polymerization of 2-ethynylpyridine by using 4-(phenylazo)benzoyl chloride without any additional initiator or catalyst in high yield. The chemical structure of poly[2-ethynyl-N-(4-(phenylazo)benzoyl) pyridinium chloride [PEPABPC] was characterized by such instrumental methods as
Santanu Mondal et al.
ACS chemical biology, 13(4), 1057-1065 (2018-03-09)
Protein arginine deiminases (PADs) play an important role in the pathogenesis of various diseases, including rheumatoid arthritis, multiple sclerosis, lupus, ulcerative colitis, and breast cancer. Therefore, the development of PAD inhibitors has drawn significant research interest in recent years. Herein



全球贸易项目编号

货号GTIN
173452-1G04061825770659